New Key Statistics Module, Z-Score and F-Score
NAS:TTNP Key Ratios
| Market Cap $ M | 4.71 |
| Enterprise Value $ M | -1.42 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.77 |
| Price/Sales | 5,150.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -6.45 |
| Beneish M-Score | 881.24 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 58.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.21 |
| EV-to-EBITDA | 0.22 |
| PEG | -- |
| Shares Outstanding M | 0.91 |
| Net Margin (%) | -495,400.00 |
| Operating Margin % | -664,300.00 |
| Pre-tax Margin (%) | -495,400.00 |
| Quick Ratio | 11.83 |
| Current Ratio | 11.83 |
| ROA % (ttm) | -89.39 |
| ROE % (ttm) | -126.92 |
| ROIC % (ttm) | -1,051.44 |
| Dividend Yield % | -- |
| Altman Z-Score | -79.07 |
TTNP Number of Guru Trades
TTNP Volume of Guru Trades
Gurus Latest Trades with NAS:TTNP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TTNP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Titan Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:TTNP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers